Tag - YMAB

Markets

Clear Street initiates coverage of several healthcare stocks

Analysts Kaveri Pohlman, PhD and Bill Maughan, PhD from Clear Street, a cloud-native financial technology firm on a mission to modernize the brokerage ecosystem, have launched coverage of several healthcare names. “The...

December 11, 2024

Markets

Janney starts Y-mAbs Therapeutics at buy; fair value estimate $45

Janney Montgomery Scott initiated coverage of Y-mAbs Therapeutics (NASDAQ:YMAB) with a “buy” rating and fair value estimate of $45. The stock closed at $35.03 on April 30. Y-mAbs is developing immunotherapies for...

May 1, 2020

Tag - YMAB

Clear Street initiates coverage of several healthcare stocks

Janney starts Y-mAbs Therapeutics at buy; fair value estimate $45

General

More